Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Interest & Investment Income of $793000.0 for Q1 2026, up 24.88% year-over-year from $635000.0 in Q1 2025, and up 137.14% quarter-over-quarter from -$2.1 million in Q4 2025.
Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 24.88% year-over-year to $793000.0; the TTM figure through Mar 2026 stood at -$526000.0 (down 132.01% YoY), while the FY2025 annual figure was -$28000.0, down 100.59% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $793000.0, up from -$2.1 million in the prior quarter.
- The five-year high for Interest & Investment Income was $1.8 million in Q2 2023, with the low at -$2.1 million in Q4 2025.
- The 5-year median for Interest & Investment Income is $143000.0 (2024), against an average of $150823.5.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income slumped 877.97% in 2022, then soared 4635.71% in 2025.
- Tenaya Therapeutics' Interest & Investment Income stood at -$1.2 million in 2022, then jumped by 113.43% to $155000.0 in 2023, then soared by 423.87% to $812000.0 in 2024, then tumbled by 362.93% to -$2.1 million in 2025, then soared by 137.14% to $793000.0 in 2026.
- Business Quant data shows TNYA's Interest & Investment Income at $793000.0 in Q1 2026, -$2.1 million in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 697,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 697,000.00 |
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | -2.14 Mn |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 635,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -28,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | -118,000.00 |
| Sep 30, 2021 | 23,000.00 |